Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 3, 2006 - Issue 3
Submit an article Journal homepage
62
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Cost-effectiveness of drug-eluting stents: real-world scrutiny of the BASKET trial of real-world usage

Liesl M Cooper Vice President, Health Economics and Reimbursement, Cordis Corporation, a Johnson & Johnson Company, 7 Powder Horn Drive, Warren, NJ 07059, USA. [email protected]
&
Walter Linde-Zwirble Vice President and Chief Scientific Officer, ZD Associates, LLC, 904 Deerfield Place, Perkasie, PA 18944, USA
Pages 305-309 | Published online: 26 Apr 2006

Bibliography

  • HOLMES DR Jr; SISR: A prospective randomized comparison of the sirolimus-eluting stent vs brachytherapy in patients with bare metal in-stent restenosis. Proceedings of the 17th Annual Transcatheter Cardiovascular Therapeutics. Washington DC, USA (2005).
  • RUSSELL LB, GOLD MR, SIEGEL JE, DANIELS N, WEINSTEIN: The role of cost-effectiveness analysis in health and medicine. JAMA (1996) 276(14):1172-1177.
  • WEINSTEIN MC, SIEGEL JE, GOLD MR, KAMLET MS, RUSSELL LB: Recommendations of the panel on cost-effectiveness in health and medicine. JAMA (1996) 276(15):1253-1258.
  • SIEGEL JE, WEINSTEIN MC, RUSSELL LB, GOLD MR: Recommendations for reporting cost-effectiveness analyses. JAMA (1996) 276(16):1339-1341.
  • SERRUYS PW, VAN HOUT B, BONNIER H et al.: Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet (1998) 352:673-681.
  • SERRUYS PW, UNGER F, SOUSA JE et al.: Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N. Engl. J. Med. (2001) 344(15):1117-1124.
  • HOLMES DR, LEON MB, MOSES JW et al.: Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomied trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation (2004) 109:634-640.
  • SCHOFER J, SCHLÜTER M, GERSHLICK AH et al.: Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet (2003) 362:1093-1099.
  • COHEN DJ, BAKHAI A, SHI C et al.: Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients with de novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation (2004) 110:508-514.
  • SHRIVE FM, MANNS BJ, GALBRAITH PD, KNUDTSON ML, GHALI WA: Economic evaluation of sirolimus- eluting stents. CMAJ (2005) 172:345-351.
  • BAGUST A, GRAYSON AD, PALMER ND, PERRY RA, WALLEY T: Cost-effectiveness of drug-eluting coronary artery stenting in a UK setting: cost-utility study. Heart (2006) 92:68-74.
  • VAN HOUT BA, SERRUYS PW, LEMOS PA et al.: One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. Heart (2005) 91:507-512.
  • KAISER C, BRUNNER-LA ROCCA HP, BUSER PT et al.: Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomized Basel Stent Kosten Effektivitats Trial (BASKET). Lancet (2005) 366(9489):921-929.
  • CUTLIP DE, CHAUHAN MS, BAIM DS et al.: Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J. Am. Coll. Cardiol. (2002) 40(12):2082-2089.
  • MORGAN STANLEY EQUITY RESEARCH: Hospital Supplies & Medical Technology. Interventional Cardiology Conference. New York, NY, USA (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.